The Europe orthopedic navigation system market size was valued at USD 15.44 million in 2014 and is expected to grow at a CAGR of 5.0% over the forecast period. Rising incidences of osteoarthritis and demand for minimally invasive surgeries for joint replacement surgery are expected to boost the demand for surgical navigation systems over the forecast period. In addition, rising expenditure on healthcare, awareness pertaining to computer assisted surgical navigation system and adoption of these techniques are some factors contributing to market growth in the coming years.
Germany orthopedic navigation system market, by application, 2012 - 2022 (USD Million)
European Commission estimates around 20% of the population to be aged above 60 years in 2025. Women are more prone to degenerative joint disorders as compared to men post the age of 50. Total age dependency ratio in Europe is expected to rise from 51.8% in 2014 to 77.9% in 2080. Age dependency ratio in 28 EU countries is projected to increase from 28.1% in 2014 to around 51% in 2080. Around 1.7 million hip fractures have been registered in 1990, and this number is expected to rise to 6 million by 2050. Growing geriatric and obese population prone to hip fractures and degenerative joint disorders is expected to provide this market with lucrative growth opportunities in near future.
Knee navigation system dominated the overall segment in terms of revenue due to the increasing usage of computer assisted surgery for knee replacement procedures and wide applications of the surgical navigation system in knee replacement surgeries. The surgical knee navigation system used in various procedures such as total knee replacement, knee cap replacement (patellofemoral arthroplasty), revision knee replacement and unicompartmental (partial) knee replacement for imaging & precision.
A study performed by the NCBI states that the estimated number of knee surgeries was valued at over 1.5 million. The fact that the number of procedures is on a constant rise will provide an attractive platform for the manufacturers to capitalize on. Additionally, favorable reimbursement policies and associated advantages related to knee navigation software are expected to boost market growth over the forecast period. Similarly, technological advancement in navigation systems such as information navigation system will improve demand over the forecast period.
On the other hand, hip surgery based navigation systems are expected to witness rapid growth in usage rates due to the increasing volume of hip replacement procedures and incidences of hip fracture, osteoarthritis, and rheumatoid arthritis. Some key problems addressed by surgical navigation systems for hip surgery include leg-length discrepancy, impingement, and instability. According to statistics published by the Centers for Disease Control and Prevention (CDC), the number of total hip replacement procedures performed in 2014 was 332,000 and is expected to grow further due to increasing geriatric population and awareness pertaining to computer-assisted hip surgeries.
Germany dominated the overall industry in 2014 at over 30.0% owing to rising adoption of automated orthopedic navigations system coupled with incidences of osteoarthritis due to growing geriatric population. Furthermore, high patient awareness levels, rising demand for minimally invasive surgeries, and presence of sophisticated healthcare infrastructure for joint replacement surgery are the other growth imparting drivers of this regional market.
The UK, on the other hand, is expected to register lucrative growth over the forecast period owing to high R&D investments aimed at joint reconstruction device development and rising level of awareness among target population and orthopedic surgeons.
According to data published by the National Joint Registry (NJR), around 160,000 knee and hip replacement surgeries are performed in the UK every year. NHS is a major healthcare institute providing funding for joint replacement procedures. From 2013, NHS also started funding joint replacement procedures for people of the UK.
Zimmer-Biomet Inc., Stryker Corp., Medtronic Plc, Brainlab AG, B. Braun Melsungen AG, MicroPort Medical, Orthokey Italia SRL, Amplitude, and DePuy Synthes, Inc are key players operating in the European orthopedic navigation systems market. The industry is competitive in nature and manufacturers are engaged in rigorous R&D to develop cost-effective and efficient products for reconstructive joint replacement surgery.
In addition, technological advancement and strategic alliance is expected to provide this market with lucrative growth platform. For example, in March 2015, DePuy Synthes entered into an agreement with an advanced imaging solutions company Radlink Inc., thereby expanding its capabilities in the field of real-time imaging solutions for hip replacement procedures.
Report Attribute |
Details |
Market size value in 2020 |
USD 48.99 million |
Revenue forecast in 2022 |
USD 22.7 million |
Growth Rate |
CAGR of 5.0% from 2016 to 2022 |
Base year for estimation |
2015 |
Historical data |
2013 - 2015 |
Forecast period |
2016 – 2022 |
Quantitative units |
Revenue in USD million and CAGR from 2016 to 2022 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, region |
Regional scope |
Europe |
Country scope |
UK; Germany; Switzerland; France; Spain; Italy; Belgium; Austria; Netherlands; Russia |
Key companies profiled |
Zimmer-Biomet Inc.; Stryker Corp.; Medtronic Plc; Brainlab AG; B. Braun Melsungen AG; MicroPort Medical; Orthokey Italia SRL; Amplitude; DePuy Synthes, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
b. The Europe orthopedic navigation system market size was estimated at USD 44.39 million in 2019 and is expected to reach USD 48.99 million in 2020.
b. The Europe orthopedic navigation system market is expected to grow at a compound annual growth rate of 10.1% from 2019 to 2025 to reach USD 78.99 million by 2025.
b. Knee application dominated the Europe orthopedic navigation system market with a share of 54.62% in 2019. This is attributable to favorable reimbursement policies and associated advantages related to knee navigation software coupled with technological advancement in navigation systems.
b. Some key players operating in the Europe orthopedic navigation system market include Zimmer-Biomet Inc., Stryker Corp., Medtronic Plc, Brainlab AG, B. Braun Melsungen AG, MicroPort Medical, Orthokey Italia SRL, Amplitude, and DePuy Synthes, Inc.
b. Key factors that are driving the Europe orthopedic navigation system market growth include rising adoption of automated orthopedic navigations system coupled with incidences of osteoarthritis due to growing geriatric population, high patient awareness levels, rising demand for minimally invasive surgeries, and presence of sophisticated healthcare infrastructure for joint replacement surgery.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.